Development and validation of the protocol for the evaluation of voice in patients with hearing impairment (PEV-SHI).
The voice of individuals with hearing impairment has been widely described, and can be compromised in all levels of the phonatory system. To develop and validate an instrument for evaluating the voice of this population. The instrument underwent the validation steps suggested by the Scientific Advisory Committee of the Medical Outcomes Trust. The study sample consisted of seventy-eight Brazilian people with cochlear implants (Experimental Group) and 78 individuals with normal hearing (Control Group), divided in groups by age range - children from 3 to 5 years; children from 6 to 10 years and adults from 18 to 46 years. The study sample participated in a voice recording of the sustained vowel /a/, connected speech and spontaneous conversation, in which three voice specialists rated using the proposed instrument. It consists of visual-analog scales of suprasegmental aspects, respiratory-phonatory coordination, resonance, phonation, additional parameters and general vocal perception. Evaluation by an expert committee and a pilot test established content validity. Reliability measures showed excellent test-retest reproducibility for the majority of the parameters. Analysis with the ROC curve showed that perceptual evaluation with the sustained vowel did not strongly differentiate individuals with cochlear implants from those with normal hearing, and the parameter "speech rate" did not differentiate the groups at all. For the connected speech and spontaneous conversation, the majority of the parameters differentiated the Experimental Group from the Control Group with an Area Under the Curve ≥0.7. The cutoff values with maximum specificity and sensitivity were 30.5 for mild, 49.0 for moderate and 69.5 for intense deviation. The Protocol for the Evaluation of Voice in Subjects with Hearing Impairment, PEV-SHI, is a reliable and useful tool for assessing the particularities of the voice of individuals with hearing impairment treated with cochlear implants and can be used in research and clinical settings to standardize evaluation and facilitate information exchange among services.